Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-21 5:22 pm Unchanged | 2022-12-05 | 13D | MusclePharm Corporation MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,021,529 8.800% | 0 (Unchanged) | Filing History |
| 2022-04-01 4:38 pm Sale | 2022-03-29 | 13D | MusclePharm Corporation MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,021,529 9.050% | -626,826 (-17.18%) | Filing History |
| 2022-02-22 11:22 am Unchanged | 2022-02-07 | 13D | MusclePharm Corporation MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,648,355 10.930% | 0 (Unchanged) | Filing History |
| 2020-12-02 4:58 pm Purchase | 2020-11-29 | 13D | MusclePharm Corporation MSLP | Drexler Ryan Charles | 31,002,836 68.000% | 11,349,057 (+57.74%) | Filing History |
| 2020-11-03 4:23 pm Purchase | 2020-11-03 | 13D | MusclePharm Corporation MSLP | Wynnefield Partners Small Cap Value, L.P. I | 2,111,874 6.400% | 100,000 (+4.97%) | Filing History |
| 2020-10-28 3:57 pm Sale | 2020-10-26 | 13D | MusclePharm Corporation MSLP | Wynnefield Partners Small Cap Value, L.P. I | 2,011,874 6.100% | -31 (-0.00%) | Filing History |
| 2020-07-13 2:07 pm Purchase | 2020-07-13 | 13D | MusclePharm Corporation MSLP | Wynnefield Partners Small Cap Value, L.P. I | 2,011,905 6.200% | 80,600 (+4.17%) | Filing History |